Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients | Ayman Elgarf

Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients

Citation:: El-Garf, A., S. Fawzy, F. Talaat, and M. abd elaziz, "Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients", The Egyptian Rheumatologist (Elsevier) , vol. 38, pp. 53-59, 2016.